ImageneBio Inc
Share · US45175G2075
· IMA
(XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ImageneBio Inc
Analyst Grade Summary
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
4
1
0
0
No Price
29.04.2026 16:43
Current Prices from ImageneBio Inc
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
IMA
USD
29.04.2026 16:43
5,93 USD
0,18 USD
+3,13 %
IEX
IMA
USD
29.04.2026 15:46
5,84 USD
0,08 USD
+1,48 %
Share Float & Liquidity
Free Float
61,07 %
Shares Float
6,83 M
Shares Outstanding
11,18 M
Company Profile for ImageneBio Inc Share
Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis
Company Data
Name
ImageneBio Inc
Company
ImageneBio Inc
Symbol
IMA
Website
https://www.inmagenebio.com
Primary Exchange
NASDAQ
ISIN
US45175G2075
Asset Class
Share
Sector
Healthcare
Industry
Biotechnology
CEO
Kristin Yarema
Market Capitalization
64 Mio
Country
United States of America
Currency
USD
Employees
0,0 T
Address
12526 High Bluff Drive, Suite 345, San Diego, CA 92130, 92130 San Diego
IPO Date
1998-02-27
Stock Splits
Date
Split
28.07.2025
1:12
ID Changes
Date
From
To
28.07.2025
IKNA
IMA
Ticker Symbols
Name
Symbol
NASDAQ
IMA
More Shares
Investors who hold ImageneBio Inc also have the following shares in their portfolio:
Stratabound Minerals Corp. Share
Teyi Pharmaceutical Group Co.,Ltd Share
